ASAIO Journal

Outcomes of Durable Mechanical Circulatory Support in Myocarditis: Analysis of the International Society for Heart and Lung Transplantation Registry for Mechanically Assisted Circulatory Support Registry. 2021

Biventricular Support Using ProtekDuo Cannula in a Child.  E124-E126. 2021

Gender Differences in Mortality after Left Ventricular Assist Device Implant: A Causal Mediation Analysis Approach.  614-621. 2021

Improvement in kidney function after ventricular assist device implantation and its influence on thromboembolism, hemorrhage, and mortality.  268-276. 2020

Innovation in Medical Devices-Lessons from the Past, Planning for the Future: Hastings Lecture 2019.  65:E82-E85. 2019

Outcomes after infections in adolescents and young adults with continuous-flow left ventricular assist devices.  65:380-388. 2019

Performance of noninvasive assessment in the diagnosis of right heart failure after left ventricular assist device.  65:449-455. 2019

Use of computed tomography in preoperative planning for heartware left ventricular assist device placement.  65:70-76. 2019

Association of pulsatility with gastrointestinal bleeding in a cohort of HeartMate II recipients.  64:472-479. 2018

Use of durable continuous-flow ventricular assist devices in patients on immunosuppression.  64:334-337. 2018

Risk models in mechanical circulatory support: A conflation of concepts.  63:239-240. 2017

Anticoagulation control in patients with ventricular assist devices.  63:759-765. 2017

Automated rotational percussion bed and bronchoscopy improves respiratory mechanics and oxygenation in ARDS patients supported with extracorporeal membrane oxygenation.  62:e27-e29. 2016

Early implementation of video capsule enteroscopy in patients with left ventricular assist devices and obscure gastrointestinal bleeding.  62:40-45. 2016

Predictors of thromboembolic events in patients with ventricular assist device.  61:640-647. 2015

A nitric oxide-releasing self-assembled peptide amphiphile nanomatrix for improving the biocompatibility of microporous hollow fibers.  61:589-595. 2015

Use of ECMO in the management of severe acute respiratory distress syndrome: A survey of academic medical centers in the United States.  61:556-563. 2015

Anti-Xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.  61:339-344. 2015

Feasibility Study of Particulate Extracellular Matrix (P-ECM) and Left Ventricular Assist Device (HVAD) Therapy in Chronic Ischemic Heart Failure Bovine Model.  61:161-169. 2015

Modern use of extracorporeal life support in pregnancy and postpartum.  61:110-114. 2015

Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.  61:107-109. 2015

Transhepatic Cannulation for Venovenous Extracorporeal Membrane Oxygenation.  61:e29-e30. 2015

Antithrombin III supplementation on extracorporeal membrane oxygenation: Impact on heparin dose and circuit life.  60:57-62. 2014

Gastrointestinal bleeding in patients with ventricular assist devices is highest immediately after implantation.  59:480-485. 2013

Use of retrospectively gated CT angiography to diagnose systolic LVAD inflow obstruction.  59:542-546. 2013

The evolution of extracorporeal life support as a bridge to lung transplantation.  59:3-10. 2013

Abdominal compartment syndrome in newborns and children supported on extracorporeal membrane oxygenation.  58:143-147. 2012

Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the seattle heart failure model.  58:93-97. 2012

Hemolysis during cardiac extracorporeal membrane oxygenation: A case-control comparison of roller pumps and centrifugal pumps in a pediatric population.  57:456-461. 2011

Accidental azygos vein extracorporeal membrane oxygenation cannulation in a neonate with premature closure of the ductus arteriosus.  57:344-345. 2011

Use of gated cardiac computed tomography angiography in the assessment of left ventricular assist device dysfunction.  57:32-37. 2011

Hemodynamic responses to continuous versus pulsatile mechanical unloading of the failing left ventricle.  56:410-416. 2010

Clot lifespan model analysis of the effects of warfarin on thrombus growth and fibrinolysis: Role of contact protein and tissue factor initiation.  55:33-40. 2009

Acute hemodynamic efficacy of a 32-ml subcutaneous counterpulsation device in a calf model of diminished cardiac function.  54:578-584. 2008

Mechanical circulatory device thrombosis: A new paradigm linking hypercoagulation and hypofibrinolysis.  54:351-358. 2008

Managing device infections: Are we progressing or is infection an insurmountable obstacle?.  51:452-455. 2005

How to run an outpatient VAD program: Overview.  47:588-589. 2001

Infection with clinical ventricular assist devices: Clinical therapy.  47:195-196. 2001

Cost-benefit analysis of extended antifungal prophylaxis in ventricular assist devices.  46:587-589. 2000

Fungal infections in ventricular assist devices.  46. 2000

High flux plasma exchange using a modified rotating membrane system.  42:957-960. 1996

Measurement of percent oxyhemoglobin by optical densitometry in perfluorocarbon supplemented blood.  42. 1996

Left atrial or ventricular cannulation beyond 30 days for a Thoratec ventricular assist device.  41. 1995

Perfluorocarbons are effective oxygen carriers in cardiopulmonary bypass.  41. 1995

Influence of longer term left ventricular assist device support on valvular regurgitation.  40. 1994

Perfluorocarbon oxygen transport: A comparative study of four oxygenator designs.  40. 1994